Form 4: Alignment Healthcare Executive Dawn Maroney Sells 30,000 Shares

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock on October 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Dawn Christine Maroney, President, Markets at Alignment Healthcare, sold 30,000 shares of common stock on October 15, 2024.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2024.
• The shares were sold at a weighted-average price of $10.7694, with individual prices ranging from $10.65 to $11.05.
• Following the transaction, Maroney directly owns 1,726,097 shares of Alignment Healthcare.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It is neutral in tone and does not inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned to avoid accusations of insider trading. The market typically views these sales in the context of the executive's overall holdings and the reasons behind the sale (e.g., diversification, tax planning).

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates